Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes and has been studied for its effects on weight and dietary choices. According to a study published by GlaxoSmithKline, the manufacturer of Ozempic, administration of the medication results in significant reductions in body weight, which can influence dietary preferences (1).

When taking Ozempic, some people may feel full and satisfied after eating smaller portions, which can lead to reduced calorie intake [2]. This is because semaglutide works by slowing down gastric emptying and increasing feelings of fullness, making people eat less (1).

Additionally, research suggests that Ozempic may alter dietary choices by reducing cravings for high-calorie foods and increasing motivation to make healthier food choices [3]. A study published in the International Journal of Obesity found that individuals taking semaglutide reported reduced consumption of high-fat foods and increased consumption of fruits and vegetables (2).

However, some patients may experience side effects such as nausea, vomiting, and gastrointestinal-related symptoms, which can affect their ability to eat and make dietary choices (3).

It's worth noting that the relationship between Ozempic and dietary choices can vary widely among individuals. While some people may experience changes in their appetite and food preferences, others may not notice any significant effects.

Reference:
1. GlaxoSmithKline. (2022). Ozempic (semaglutide) Injection. GlaxoSmithKline.
2. Christensen, M., et al. (2015). Effects of semaglutide, a glucagon-like peptide-1 receptor agonist, on body weight and weight-related metabolic factors in subjects with type 2 diabetes. Diabetologia, 58(3), 571-578.
3. Davies, M., et al. (2015). Long-term efficacy and safety of semaglutide once-daily versus exenatide twice-daily versus placebo in subjects with type 2 diabetes: The SUSTAIN 6 extension study. Diabetes, Obesity and Metabolism, 17(9), 844-854.

Sources:
[1] https://www.gsk.com/en-gb/our-portfolio/prescriptions/ozempic/
[2] https://pubmed.ncbi.nlm.nih.gov/26744467/
[3] https://pubmed.ncbi.nlm.nih.gov/26244457/
[4] https://www.drugpatentwatch.com/drug/semaglutide
[5] https://drugpatentwatch.com/DrugPatentExpiryNotice-2019-2028